Modelled DT Structure
Method:homology modeling
Template PDB:4YZF_A
Identity:58.207%
Minimized Score:-1903.285 kcal/mol
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0383 | ||||
| Gene Name | SLC4A2 | ||||
| Protein Name | Anion exchange protein 2 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method:homology modeling Template PDB:4YZF_A Identity:58.207% Minimized Score:-1903.285 kcal/mol Detail: Structure Info |
||||
| Synonyms | AE 2; AE2; Anion exchanger 2; BND3L; EPB3L1; HKB3; MPB3L; NBND3; Non-erythroid band 3-like protein; SLC4A2; Solute carrier family 4 member 2 | ||||
| DT Family | Anion Exchanger (AE) Family ; | ||||
| Function | This transporter is a plasma membrane anion exchange protein of wide distribution. | ||||
| Endogenous Substrate(s) | Cl- | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 4.0) |
|||||
|
(α) Tissue Distribution Level of Anion exchange protein 2 |
|||||
|
(β) Cell Distribution Level of Anion exchange protein 2 |
|||||
|
(γ) Organelle Distribution Level of Anion exchange protein 2 |
|||||
|
Regulatory Variability Data of This DT |
|||||
|
(β) Post-translational Modification of Anion exchange protein 2 |
|||||
|
(γ) Transcriptional Regulation of Anion exchange protein 2 |
|||||
|
(δ) Epigenetic Regulation of Anion exchange protein 2 |
|||||
|
(ε) Exogenous Modulation of Anion exchange protein 2 |
|||||
|
Structural Variability Data of This DT |
|||||
|
(α) Mutation-induced Structural Variation |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
(γ) Outward/inward-facing Conformation |
|||||
|
General Variability Data of This DT |
|||||
|
(α) Genetic Polymorphisms of Anion exchange protein 2 |
|||||
|
(β) Disease-specific Protein Abundances of Anion exchange protein 2 |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Bicarbonate
|
Phase 3 | Drug Info | Metabolic acidosis | 5C73 | [1] |
| References | |||||
| 1 | HCO3-/Cl- anion exchanger SLC4A2 is required for proper osteoclast differentiation and function. Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):16934-9. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.